Reckitt's the latest to exit bidding for Pfizer's consumer business. Should Pfizer still sell?
admin 22nd March 2018 Uncategorised 0Reckitt Benckiser is officially bowing out of the race for Pfizer’s consumer health unit, paving the way for GlaxoSmithKline to make a move. But at least one analyst thinks Pfizer shouldn’t go through with a sale.
More: Reckitt's the latest to exit bidding for Pfizer's consumer business. Should Pfizer still sell?
Source: fierce